Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-selective antibodies
Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-selective antibodies. J Neurosci 1991; 11: 3218-26.
Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: Distribution of m4 and m5 receptors in rat brain
Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, et al. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Mol Pharmacol 1993; 43: 149-57.
Agonist-like activity of anti-peptide antibodies directed against an autoimmune epitope on the heart muscarinic acetylcholine receptor
Fu ML. Agonist-like activity of anti-peptide antibodies directed against an autoimmune epitope on the heart muscarinic acetylcholine receptor. Receptors-Channels 1994; 2: 121-30.
The affinity of some selective muscarinic receptor antagonists for the muscarinic receptor mediating endothelium-dependent relexation of the rabbit and rat thoracic aorta
Choo LK, Malta E, Mitchelson F. The affinity of some selective muscarinic receptor antagonists for the muscarinic receptor mediating endothelium-dependent relexation of the rabbit and rat thoracic aorta. J Pharm Pharmacol 1986; 38: 843-5.
Mediation by m3-muscarinic receptors of both endothelium-dependent contraction and relexation to acetylcholine in the aorta of spontaneously hypertensive rat
Boulanger CM, Morrison KJ, Vanhoutte PM. Mediation by m3-muscarinic receptors of both endothelium-dependent contraction and relexation to acetylcholine in the aorta of spontaneously hypertensive rat. Br J Pharmacol 1994; 112: 519-24.
Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors
Doods HN, Mathy MJ, Davidesko D, van Charldorp KJ, de Jonge A, van Zwieten PA. Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther 1987; 242: 257-62.